Quintiles tweaks Apple's ResearchKit for use in biopharma-sponsored trials

Quintiles ($Q) has made changes to Apple's ($AAPL) open-source ResearchKit framework. The CRO made the enhancements--the code for which it released on the GitHub repository--to make Apple's platform more suitable for the trials it oversees. "We want to be the leader when it comes to collaboration with technology giants such as Apple," a spokesperson for Quintiles told Outsourcing-Pharma.com. Article | More

Read more on